Saptarsi M. Haldar

Saptarsi M. Haldar

Auto-generated profile, based on publicly available information

Saptarsi M. Haldar

Amgen Research, South San Francisco, California, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Cell
Verified
Journal Article
Closed access
PAPriti Anand
Priti Anand
JBJonathan D. Brown
Jonathan D. Brown
CLCharles Y. Lin
Charles Y. Lin
JQJun Qi
Jun Qi
RZRongli Zhang
Rongli Zhang
SHSaptarsi M. Haldar
Saptarsi M. Haldar

17 May 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
QDQiming Duan
Qiming Duan
SMSarah McMahon
Sarah McMahon
PAPriti Anand
Priti Anand
HSHirsh Shah
Hirsh Shah
STSean Thomas
Sean Thomas
SHSaptarsi M. Haldar
Saptarsi M. Haldar
BET bromodomain inhibition treats heart failure by blocking innate inflammatory and profibrotic gene networks.

23 June 2021 in Nature
Verified
Journal Article
Closed access
PDF file
MAMichael Alexanian
Michael Alexanian
PPPawel F. Przytycki
Pawel F. Przytycki
RMRudi Micheletti
Rudi Micheletti
APArun Padmanabhan
Arun Padmanabhan
LYLin Ye
Lin Ye
DSDeepak Srivastava
Deepak Srivastava

1 February 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DPDomenick A. Prosdocimo
Domenick A. Prosdocimo
PAPriti Anand
Priti Anand
XLXudong Liao
Xudong Liao
HZHan Zhu
Han Zhu
SSShamanthika Shelkay
Shamanthika Shelkay
SHSaptarsi M. Haldar
Saptarsi M. Haldar
The mammalian heart, the body's largest energy consumer, has evolved robust mechanisms to tightly couple fuel supply with energy demand across a wide range of physiologic and pathophysiologic states, yet, when compared with other organs, relatively little is known about the molecular machinery that directly governs metabolic plasticity in the heart. Although previous studies have defined Kruppel-like factor 15 (KLF15) as a transcriptional repressor of pathologic cardiac hypertrophy, a direct role for the KLF family in cardiac metabolism has not been previously established. We show in human heart samples that KLF15 is induced after birth and reduced in heart failure, a myocardial expression pattern that parallels reliance on lipid oxidation. Isolated working heart studies and unbiased transcriptomic profiling in Klf15-deficient hearts demonstrate that KLF15 is an essential regulator of lipid flux and metabolic homeostasis in the adult myocardium. An important mechanism by which KLF15 regulates its direct transcriptional targets is via interaction with p300 and recruitment of this critical co-activator to promoters. This study establishes KLF15 as a key regulator of myocardial lipid utilization and is the first to implicate the KLF transcription factor family in cardiac metabolism.

9 April 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SHSaptarsi M. Haldar
Saptarsi M. Haldar
DJDarwin Jeyaraj
Darwin Jeyaraj
PAPriti Anand
Priti Anand
HZHan Zhu
Han Zhu
YLYuan Lu
Yuan Lu
MJMukesh K. Jain
Mukesh K. Jain
The ability of skeletal muscle to enhance lipid utilization during exercise is a form of metabolic plasticity essential for survival. Conversely, metabolic inflexibility in muscle can cause organ dysfunction and disease. Although the transcription factor Kruppel-like factor 15 (KLF15) is an important regulator of glucose and amino acid metabolism, its endogenous role in lipid homeostasis and muscle physiology is unknown. Here we demonstrate that KLF15 is essential for skeletal muscle lipid utilization and physiologic performance. KLF15 directly regulates a broad transcriptional program spanning all major segments of the lipid-flux pathway in muscle. Consequently, Klf15 -deficient mice have abnormal lipid and energy flux, excessive reliance on carbohydrate fuels, exaggerated muscle fatigue, and impaired endurance exercise capacity. Elucidation of this heretofore unrecognized role for KLF15 now implicates this factor as a central component of the transcriptional circuitry that coordinates physiologic flux of all three basic cellular nutrients: glucose, amino acids, and lipids.

2 January 2013 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SHSaptarsi M. Haldar
Saptarsi M. Haldar
JSJonathan S. Stamler
Jonathan S. Stamler
Delivery of oxygen to tissues is the primary function of the cardiovascular system. NO, a gasotransmitter that signals predominantly through protein S-nitrosylation to form S-nitrosothiols (SNOs) in target proteins, operates coordinately with oxygen in mammalian cellular systems. From this perspective, SNO-based signaling may have evolved as a major transducer of the cellular oxygen-sensing machinery that underlies global cardiovascular function. Here we review mechanisms that regulate S-nitrosylation in the context of its essential role in “systems-level” control of oxygen sensing, delivery, and utilization in the cardiovascular system, and we highlight examples of aberrant S-nitrosylation that may lead to altered oxygen homeostasis in cardiovascular diseases. Thus, through a bird’s-eye view of S-nitrosylation in the cardiovascular system, we provide a conceptual framework that may be broadly applicable to the functioning of other cellular systems and physiological processes and that illuminates new therapeutic promise in cardiovascular medicine.